Biotech Distilled 133 companies · 839 active programs

Substack ↗ Subscribe

Therapeutic Areas Modalities Phases Targets Companies

Home › Targets › Nav1.2

Nav1.2 (1 companies · 1 programs)

Companies with an active program directed at Nav1.2.

Xenon Pharmaceuticals Inc. XENE

NBI-921355 — Epilepsy Phase 1

About Feedback Report a bug Substack ↗

This website is an encyclopedia of clinical-stage biotech companies, refreshed weekly. For informational and educational use only — not investment advice. Always verify against primary sources before making decisions.